Vimarsana
Biggest News Aggregation in the World

Page 4 - Don Hunter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Don Hunter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Don Hunter Today - Breaking & Trending Today

I have a picture for you! 4 December - 10 December 2022 - Vimarsana News

I have a picture for you! 4 December - 10 December 2022

The First Thing newsletter's Ever-lasting Subscriber Photo Gallery.

PTSD: Clinical trial examines 'magic' mushrooms as treatment - Vimarsana News

PTSD: Clinical trial examines 'magic' mushrooms as treatment

A Nova Scotia-based company has received Health Canada approval to conduct a clinical trial to determine if psilocybin, a psychedelic compound found in 'magic' mushrooms, can help those with PTSD who are treatment-resistant.

Source: ctvnews.ca
N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD - Vimarsana News

N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD

Halucenex Life Sciences Inc. in Windsor, N.S., is in the midst of the province's first clinical trial using the psychoactive substance psilocybin. Researchers hope to demonstrate the efficacy of the drug for treating post-traumatic stress disorder.

Source: cbc.ca
Greenlane Holdings, Inc.: Greenlane Announces Management Changes In Connection With Transition to Consumer Brands Business Model - Vimarsana News

Greenlane Holdings, Inc.: Greenlane Announces Management Changes In Connection With Transition to Consumer Brands Business Model

Company announces upcoming CEO change and potential changes to the Board of Directors.BOCA RATON, FL / ACCESSWIRE / October 7, 2022 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN)

Pinehurst Planning Board Votes Against Prohibiting STRs - Vimarsana News

Pinehurst Planning Board Votes Against Prohibiting STRs

Note: This article was updated on Sept. 8, 2022.